Preparation and applications of artificial mucins in biomedicine

Rachel E Detwiler1, Jessica R Kramer1

  • 1Department of Biomedical Engineering, University of Utah, 36 S. Wasatch Dr., Salt Lake City, UT 84112, USA.

Current Opinion in Solid State & Materials Science
|June 7, 2023
PubMed

Insights

Artificial mucins offer precisely tunable structures for studying mucus barrier functions. This review highlights advances in designing and synthesizing these synthetic materials for biomedical applications.

Area of Science:

  • Biomaterials Science
  • Biochemistry
  • Cell Biology

Background:

  • Mucus forms a critical biological barrier, regulating transport and protecting cells.
  • Mucin glycoproteins are key components of mucus and the epithelial glycocalyx.
  • Diseases like cancer and infection are linked to abnormal mucin production, yet their complex structures hinder understanding.

Purpose of the Study:

  • To review advancements in the design and synthesis of artificial mucins.
  • To explore the applications of artificial mucins in biomedical research.
  • To bridge the gap in understanding mucin chemistry, biology, and physics.

Main Methods:

  • Highlighting innovative strategies for synthesizing artificial mucins with controlled structures.
  • Discussing the use of synthetic mucins to mimic biological barrier functions.
  • Reviewing studies employing artificial mucins to investigate mucin-related diseases and processes.

Main Results:

  • Artificial mucins provide a platform for precise structural control, overcoming biological heterogeneity.
  • Synthetic materials enable detailed investigation of mucin's roles in transport regulation and cell protection.
  • These engineered materials facilitate research into mucin's involvement in disease pathogenesis.

Conclusions:

  • Artificial mucins are valuable tools for dissecting the complex functions of biological mucins.
  • Advances in synthesis allow for tailored biomaterials to study mucin chemistry, biology, and physics.
  • This field holds promise for developing new therapeutic strategies for mucin-related diseases.

Related Concept Videos

Glycosaminoglycans01:23

Glycosaminoglycans

Glycosaminoglycans (GAGs), also known as mucopolysaccharides, are long and linear polymers comprising of specific repeating disaccharides - the amino sugar that can be N-acetylglucosamine or N-acetylgalactosamine, and a uronic acid that is usually glucuronic acid or iduronic acid.
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
4.9K
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
300
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.0K